why choose us

First received: September 11, 2023

Clinical Trial: Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hidradenitis Suppurativa

Study Type: INTERVENTIONAL


Official Title: Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

Brief Summary: HS is relatively common in the United States with a prevalence of 0.1-1.0%. 1 HS has a dramatic impact on quality of life, significantly more so than other chronic skin diseases, such as psoriasis or atopic dermatitis (AD).HS also has a large economic impact, due to frequent emergency department and inpatient care utilization, and re-hospitalization rates similar to congestive heart failure.Unfortunately, few treatment options are effective.There is only one currently FDA-approved treatment, adalimumab, but only…

Read more